Skye Bioscience, Inc. Common Stock (SKYE) — Free Cash Flow Generation Index
Skye Bioscience, Inc. Common Stock (SKYE) has a Free Cash Flow Generation Index of -7.56x as of June 2014. Free cash flow of $-59.91K represents -8% of operating cash flow ($7.92K). See SKYE net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Skye Bioscience, Inc. Common Stock Free Cash Flow Generation Index (2012–2012)
Historical FCF Generation Index trend for Skye Bioscience, Inc. Common Stock across 1 annual periods. Explore how well can Skye Bioscience, Inc. Common Stock service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Skye Bioscience, Inc. Common Stock (2012–2012)
Year-by-year Free Cash Flow Generation Index for Skye Bioscience, Inc. Common Stock. For the full company profile including market capitalisation, see Skye Bioscience, Inc. Common Stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2012 | 1.00x | $1.93K | $1.93K | $0.00 | — |